Financials Sopharma Properties REIT

Equities

SFI

BG1100031068

Diversified REITs

End-of-day quote Bulgaria S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
8.7 BGN -.--% Intraday chart for Sopharma Properties REIT -.--% +1.75%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 133.1 138.1 125.1 175.6 206.3 187.7
Enterprise Value (EV) 1 149.7 151.2 134.1 181.7 209 186.2
P/E ratio 19.6 x 18.9 x 17.5 x 19.4 x 20.1 x 15.9 x
Yield 4.22% 4.4% 2.88% 2.08% 1.76% -
Capitalization / Revenue 12.5 x 12.4 x 11.4 x 16.7 x 19.3 x 15.4 x
EV / Revenue 14 x 13.6 x 12.2 x 17.3 x 19.5 x 15.3 x
EV / EBITDA 22.4 x 21.3 x 18.8 x 25.1 x 30.7 x 23.5 x
EV / FCF 46.5 x 36.6 x 28.6 x 46 x 52.6 x 39.8 x
FCF Yield 2.15% 2.73% 3.5% 2.17% 1.9% 2.51%
Price to Book 2.31 x 2.24 x 1.91 x 2.39 x 2.57 x 2.12 x
Nbr of stocks (in thousands) 20,954 21,416 21,951 21,951 21,951 21,951
Reference price 2 6.350 6.450 5.700 8.000 9.400 8.550
Announcement Date 3/29/19 1/30/20 1/29/21 1/31/22 3/23/23 1/30/24
1BGN in Million2BGN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 10.66 11.15 11.01 10.51 10.69 12.19
EBITDA 1 6.676 7.084 7.132 7.253 6.817 7.93
EBIT 1 6.671 7.079 7.127 7.247 6.807 7.921
Operating Margin 62.56% 63.48% 64.73% 68.95% 63.68% 64.97%
Earnings before Tax (EBT) 1 6.614 7.187 7.011 9.071 10.27 11.83
Net income 1 6.614 7.187 7.011 9.071 10.27 11.83
Net margin 62.02% 64.45% 63.67% 86.31% 96.04% 97.05%
EPS 2 0.3246 0.3405 0.3252 0.4132 0.4677 0.5390
Free Cash Flow 1 3.222 4.134 4.69 3.949 3.974 4.679
FCF margin 30.21% 37.07% 42.59% 37.58% 37.17% 38.38%
FCF Conversion (EBITDA) 48.26% 58.35% 65.76% 54.45% 58.29% 59.01%
FCF Conversion (Net income) 48.71% 57.52% 66.89% 43.54% 38.7% 39.55%
Dividend per Share 2 0.2680 0.2840 0.1640 0.1660 0.1650 -
Announcement Date 3/29/19 1/30/20 1/29/21 1/31/22 3/23/23 1/30/24
1BGN in Million2BGN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 16.7 13.1 9.03 6.08 2.64 -
Net Cash position 1 - - - - - 1.47
Leverage (Debt/EBITDA) 2.495 x 1.848 x 1.266 x 0.8385 x 0.3876 x -
Free Cash Flow 1 3.22 4.13 4.69 3.95 3.97 4.68
ROE (net income / shareholders' equity) 12.2% 12.1% 11% 12.8% 13.3% 14%
ROA (Net income/ Total Assets) 4.94% 5.2% 5.16% 5.16% 4.7% 5.24%
Assets 1 133.9 138.2 135.8 175.8 218.5 225.8
Book Value Per Share 2 2.750 2.880 2.980 3.350 3.660 4.040
Cash Flow per Share 2 0.0100 0.0300 0.0800 0.0700 0.0900 0.0900
Capex 1 0.03 0.15 0.03 0.11 0.01 -
Capex / Sales 0.32% 1.31% 0.31% 1.02% 0.06% -
Announcement Date 3/29/19 1/30/20 1/29/21 1/31/22 3/23/23 1/30/24
1BGN in Million2BGN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SFI Stock
  4. Financials Sopharma Properties REIT